Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Xinwei Zou, Chenjie Zhu, Lin Zhang, Yi Zhang, Fengqing Fu, Youguo Chen & Jinhua Zhou. (2020) MicroRNA-708 Suppresses Cell Proliferation and Enhances Chemosensitivity of Cervical Cancer Cells to cDDP by Negatively Targeting Timeless. OncoTargets and Therapy 13, pages 225-235.
Read now
Read now
A. Balupuri, P.K. Balasubramanian, C.G. Gadhe & S.J. Cho. (2014) Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors. SAR and QSAR in Environmental Research 25:8, pages 651-671.
Read now
Read now
Laura Carrassa, Rosaria Chilà, Monica Lupi, Francesca Ricci, Cinzia Celenza, Marco Mazzoletti, Massimo Broggini & Giovanna Damia. (2012) Combined inhibition of Chk1 and Wee1: In vitro synergistic effect translates to tumor growth inhibition in vivo. Cell Cycle 11:13, pages 2507-2517.
Read now
Read now
Lei Chen, Shi-Bin Chao, Zhen-Bo Wang, Shu-Tao Qi, Xiu-Lan Zhu, Shang-Wu Yang, Cai-Rong Yang, Qing-Hua Zhang, Ying-Chun Ouyang, Yi Hou, Heide Schatten & Qing-Yuan Sun. (2012) Checkpoint kinase 1 is essential for meiotic cell cycle regulation in mouse oocytes. Cell Cycle 11:10, pages 1948-1955.
Read now
Read now
Articles from other publishers (54)
Yuri Tozaki, Hiromasa Aoki, Rina Kato, Kohki Toriuchi, Saki Arame, Yasumichi Inoue, Hidetoshi Hayashi, Eiji Kubota, Hiromi Kataoka & Mineyoshi Aoyama. (2023) The Combination of ATM and Chk1 Inhibitors Induces Synthetic Lethality in Colorectal Cancer Cells. Cancers 15:3, pages 735.
Crossref
Crossref
Ryo Nakamichi, Yuta Fujii & Hiroshi Asahara. 2023. Cartilage: From Biology to Biofabrication. Cartilage: From Biology to Biofabrication
155
208
.
Kiyohiro Ando, Miki Ohira, Ichiro Takada, Verna Cázares‐Ordoñez, Yusuke Suenaga, Hiroki Nagase, Shinichi Kobayashi, Tsugumichi Koshinaga, Takehiko Kamijo, Makoto Makishima & Satoshi Wada. (2021) FGFR2 loss sensitizes MYCN‐amplified neuroblastoma CHP134 cells to CHK1 inhibitor–induced apoptosis. Cancer Science 113:2, pages 587-596.
Crossref
Crossref
Benjamin R. Stromberg, Mayank Singh, Adrian E. Torres, Amy C. Burrows, Debjani Pal, Christine Insinna, Yosup Rhee, Andrew S. Dickson, Christopher J. Westlake & Matthew K. Summers. (2021) The deubiquitinating enzyme USP37 enhances CHK1 activity to promote the cellular response to replication stress. Journal of Biological Chemistry 297:4, pages 101184.
Crossref
Crossref
Jingyuan Sun, Zhenru Zhu, Wenwen Li, Mengying Shen, Chuanhui Cao, Qingcan Sun, Zeqin Guo, Li Liu & Dehua Wu. (2020) UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Crossref
Rosa Santangelo, Enrico Rizzarelli & Agata Copani. (2020) Role for Metallothionein-3 in the Resistance of Human U87 Glioblastoma Cells to Temozolomide. ACS Omega 5:29, pages 17900-17907.
Crossref
Crossref
Jessica Ceramella, Domenico Iacopetta, Alexia Barbarossa, Anna Caruso, Fedora Grande, Maria Grazia Bonomo, Annaluisa Mariconda, Pasquale Longo, Saturnino Carmela & Maria Stefania Sinicropi. (2020) Carbazole Derivatives as Kinase-Targeting Inhibitors for Cancer Treatment. Mini-Reviews in Medicinal Chemistry 20:6, pages 444-465.
Crossref
Crossref
Liping Xie, Limin Jia, Jinyue Qu, Dong Chen, Yanhong Lv, Haixia Li & Jinhua Zheng. (2020) Expression and prognostic significance of the P53‐related DNA damage repair proteins checkpoint kinase 1 (CHK1) and growth arrest and DNA‐damage‐inducible 45 alpha (GADD45A) in human oral squamous cell carcinoma. European Journal of Oral Sciences 128:2, pages 128-135.
Crossref
Crossref
Linzhi Yan, Min Lin, Shuya Pan, Yehuda G. Assaraf, Zhi-wei Wang & Xueqiong Zhu. (2020) Emerging roles of F-box proteins in cancer drug resistance. Drug Resistance Updates 49, pages 100673.
Crossref
Crossref
Kiyohiro Ando, Yohko Nakamura, Hiroki Nagase, Akira Nakagawara, Tsugumichi Koshinaga, Satoshi Wada & Makoto Makishima. (2019) Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells. International Journal of Molecular Sciences 20:15, pages 3700.
Crossref
Crossref
Lexian Tong, Pinrao Song, Kailong Jiang, Lei Xu, Tingting Jin, Peipei Wang, Xiaobei Hu, Sui Fang, Anhui Gao, Yubo Zhou, Tao Liu, Jia Li & Yongzhou Hu. (2019) Discovery of (R)-5-((5-(1-methyl-1H-pyrazol-4-yl)-4-(methylamino)pyrimidin-2-yl)amino)-3-(piperidin-3-yloxy)picolinonitrile, a novel CHK1 inhibitor for hematologic malignancies. European Journal of Medicinal Chemistry 173, pages 44-62.
Crossref
Crossref
Lin Cai, Jingduo Li, Jing Zhao, Yingxue Guo, Menghua Xie, Xiupeng Zhang, Liang Wang, Hua Tian, Ailin Li, Qingchang Li & Yuan Miao. (2019)
Fbxo6 confers drug‐sensitization to cisplatin
via
inhibiting the activation of Chk1 in non‐small cell lung cancer
. FEBS Letters 593:14, pages 1827-1836.
Crossref
Crossref
Hussein H. K. Abbas, Kheloud M. H. Alhamoudi, Mark D. Evans, George D. D. Jones & Steven S. Foster. (2018) MTH1 deficiency selectively increases non-cytotoxic oxidative DNA damage in lung cancer cells: more bad news than good?. BMC Cancer 18:1.
Crossref
Crossref
John Inge Johnsen, Cecilia Dyberg, Susanne Fransson & Malin Wickström. (2018) Molecular mechanisms and therapeutic targets in neuroblastoma. Pharmacological Research 131, pages 164-176.
Crossref
Crossref
Jac A. Nickoloff. (2017) Paths from DNA damage and signaling to genome rearrangements via homologous recombination. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 806, pages 64-74.
Crossref
Crossref
Kwang Kim, Kyu Choi & Sangwoo Bae. (2016) A novel Chk1-binding peptide that enhances genotoxic sensitivity through the cellular redistribution of nuclear Chk1. International Journal of Molecular Medicine.
Crossref
Crossref
Suzanne J. Randle & Heike Laman. (2016) F-box protein interactions with the hallmark pathways in cancer. Seminars in Cancer Biology 36, pages 3-17.
Crossref
Crossref
Denis Velic, Anthony Couturier, Maria Ferreira, Amélie Rodrigue, Guy Poirier, Fabrice Fleury & Jean-Yves Masson. (2015) DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles’ Heel of Cancer. Biomolecules 5:4, pages 3204-3259.
Crossref
Crossref
Céline Baldeyron, Amélie Brisson, Bruno Tesson, Fariba Némati, Stéphane Koundrioukoff, Elie Saliba, Leanne De Koning, Elise Martel, Mengliang Ye, Guillem Rigaill, Didier Meseure, André Nicolas, David Gentien, Didier Decaudin, Michelle Debatisse, Stéphane Depil, Francisco Cruzalegui, Alain Pierré, Sergio Roman-Roman, Gordon C. Tucker & Thierry Dubois. (2015) TIPIN depletion leads to apoptosis in breast cancer cells. Molecular Oncology 9:8, pages 1580-1598.
Crossref
Crossref
JIAN GONG, JUAN CAO, GUINAN LIU & JI-RONG HUO. (2015) Function and mechanism of F-box proteins in gastric cancer (Review). International Journal of Oncology 47:1, pages 43-50.
Crossref
Crossref
Adil I. DaudMichelle T. AshworthJonathan StrosbergJonathan W. GoldmanDavid MendelsonGregory SpringettAlan P. VenookSabine LoechnerLee S. RosenFrances ShanahanDavid ParryStuart ShumwayJennifer A. GrabowskyTomoko FreshwaterChristopher SorgeSoonmo Peter KangRandi IsaacsPamela N. Munster. (2015) Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors. Journal of Clinical Oncology 33:9, pages 1060-1066.
Crossref
Crossref
M M Al-kaabi, A T Alshareeda, D A Jerjees, A A Muftah, A R Green, N H Alsubhi, C C Nolan, S Chan, E Cornford, S Madhusudan, I O Ellis & E A Rakha. (2015) Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response. British Journal of Cancer 112:5, pages 901-911.
Crossref
Crossref
Tarek M.A. Abdel-Fatah, Fiona K. Middleton, Arvind Arora, Devika Agarwal, Tao Chen, Paul M. Moseley, Christina Perry, Rachel Doherty, Stephen Chan, Andrew R. Green, Emad Rakha, Graham Ball, Ian O. Ellis, Nicola J. Curtin & Srinivasan Madhusudan. (2015) Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer. Molecular Oncology 9:3, pages 569-585.
Crossref
Crossref
Haiqin Yun, Ranran Shi, Qingrui Yang, Xiaofang Zhang, Yan Wang, Xingchen Zhou & Kun Mu. (2014) Over expression of hRad9 protein correlates with reduced chemosensitivity in breast cancer with administration of neoadjuvant chemotherapy. Scientific Reports 4:1.
Crossref
Crossref
JIAN GONG, LIANG LV & JIRONG HUO. (2014) Roles of F-box proteins in human digestive system tumors (Review). International Journal of Oncology 45:6, pages 2199-2207.
Crossref
Crossref
Emiliano Calvo, Victor J. Chen, Mark Marshall, Ute Ohnmacht, Scott M. Hynes, Elizabeth Kumm, H. Bruce Diaz, Darlene Barnard, Farhana F. Merzoug, Lysiane Huber, Lisa Kays, Philip Iversen, Antonio Calles, Beatrice Voss, Aimee Bence Lin, Nicolas Dickgreber, Thomas Wehler & Martin Sebastian. (2014) Preclinical analyses and phase I evaluation of LY2603618 administered in combination with Pemetrexed and cisplatin in patients with advanced cancer. Investigational New Drugs 32:5, pages 955-968.
Crossref
Crossref
Yin Xie, Rong-Rong Wei, Guo-Liang Huang, Mei-Yin Zhang, Yun-Fei Yuan & Hui-Yun Wang. (2014) Checkpoint kinase 1 is negatively regulated by miR-497 in hepatocellular carcinoma. Medical Oncology 31:3.
Crossref
Crossref
Youwei Zhang & Tony Hunter. (2013) Roles of Chk1 in cell biology and cancer therapy. International Journal of Cancer 134:5, pages 1013-1023.
Crossref
Crossref
IRENE QUATTRINI, AMALIA CONTI, LAURA PAZZAGLIA, CHIARA NOVELLO, STEFANO FERRARI, PIERO PICCI & MARIA SERENA BENASSI. (2014) Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation. Oncology Reports 31:1, pages 370-375.
Crossref
Crossref
Enrique Hernández-Lemus. 2014. Omics Approaches in Breast Cancer. Omics Approaches in Breast Cancer
333
352
.
Hiroyuki Inuzuka & Wenyi WeiJianping Guo, Brian J. North, Adriana E. Tron, Hiroyuki Inuzuka & Wenyi Wei. 2014. SCF and APC E3 Ubiquitin Ligases in Tumorigenesis. SCF and APC E3 Ubiquitin Ligases in Tumorigenesis
73
87
.
Hiroyuki Inuzuka & Wenyi WeiBrian J. North, Yueyong Liu, Hiroyuki Inuzuka & Wenyi Wei. 2014. SCF and APC E3 Ubiquitin Ligases in Tumorigenesis. SCF and APC E3 Ubiquitin Ligases in Tumorigenesis
47
71
.
Elizabeth Blackwood, Jennifer Epler, Ivana Yen, Michael Flagella, Tom O'Brien, Marie Evangelista, Stephen Schmidt, Yang Xiao, Jonathan Choi, Kaska Kowanetz, Judi Ramiscal, Kenton Wong, Diana Jakubiak, Sharon Yee, Gary Cain, Lewis Gazzard, Karen Williams, Jason Halladay, Peter K. Jackson & Shiva Malek. (2013) Combination Drug Scheduling Defines a “Window of Opportunity” for Chemopotentiation of Gemcitabine by an Orally Bioavailable, Selective ChK1 Inhibitor, GNE-900. Molecular Cancer Therapeutics 12:10, pages 1968-1980.
Crossref
Crossref
A.M. Gonzalez-Angulo, S. Liu, H. Chen, M. Chavez-MacGregor, A. Sahin, G.N. Hortobagyi, G.B. Mills, K.-A. Do & F. Meric-Bernstam. (2013) Functional proteomics characterization of residual breast cancer after neoadjuvant systemic chemotherapy. Annals of Oncology 24:4, pages 909-916.
Crossref
Crossref
Glen J. Weiss, Ross C. Donehower, Tara Iyengar, Ramesh K. Ramanathan, Karen Lewandowski, Eric Westin, Karla Hurt, Scott M. Hynes, Stephen P. Anthony & Scott McKane. (2012) Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500 mg/m2 every 21 days in patients with cancer. Investigational New Drugs 31:1, pages 136-144.
Crossref
Crossref
Inken Wierstra. 2013.
97
398
.
XIAOBIN WANG, ZHIKUN MA, ZHENG XIAO, HUI LIU, ZHONGLING DOU, XIAOSHAN FENG & HAIJUN SHI. (2012) Chk1 knockdown confers radiosensitization in prostate cancer stem cells. Oncology Reports 28:6, pages 2247-2254.
Crossref
Crossref
S. Liu, S. O. Opiyo, K. Manthey, J. G. Glanzer, A. K. Ashley, C. Amerin, K. Troksa, M. Shrivastav, J. A. Nickoloff & G. G. Oakley. (2012) Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress. Nucleic Acids Research 40:21, pages 10780-10794.
Crossref
Crossref
James A. McCubrey, Linda S. Steelman, William H. Chappell, Stephen L. Abrams, Richard A. Franklin, Giuseppe Montalto, Melchiorre Cervello, Massimo Libra, Saverio Candido, Grazia Malaponte, Maria C. Mazzarino, Paolo Fagone, Ferdinando Nicoletti, Jörg Bäsecke, Sanja Mijatovic, Danijela Maksimovic-Ivanic, Michele Milella, Agostino Tafuri, Francesca Chiarini, Camilla Evangelisti, Lucio Cocco & Alberto M. Martelli. (2012) Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance. Oncotarget 3:10, pages 1068-1111.
Crossref
Crossref
Jian Hong, Kaishun Hu, Yunfei Yuan, Yi Sang, Qiangui Bu, Guihua Chen, Longjun Yang, Binkui Li, Pinzhu Huang, Dongtai Chen, Yi Liang, Ruhua Zhang, Jingxuan Pan, Yi-Xin Zeng & Tiebang Kang. (2012) CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma. Journal of Clinical Investigation 122:6, pages 2165-2175.
Crossref
Crossref
M Bartucci, S Svensson, P Romania, R Dattilo, M Patrizii, M Signore, S Navarra, F Lotti, M Biffoni, E Pilozzi, E Duranti, S Martinelli, C Rinaldo, A Zeuner, M Maugeri-Saccà, A Eramo & R De Maria. (2011) Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy. Cell Death & Differentiation 19:5, pages 768-778.
Crossref
Crossref
Bin Liu, Ying Zheng, Tong-Dan Wang, Han-Zhang Xu, Li Xia, Jian Zhang, Ying-Li Wu, Guo-Qiang Chen & Li-Shun Wang. (2012) Proteomic Identification of Common SCF Ubiquitin Ligase FBXO6-Interacting Glycoproteins in Three kinds of Cells. Journal of Proteome Research 11:3, pages 1773-1781.
Crossref
Crossref
Hsing-Chen Tsai, Huili Li, Leander Van Neste, Yi Cai, Carine Robert, Feyruz V. Rassool, James J. Shin, Kirsten M. Harbom, Robert Beaty, Emmanouil Pappou, James Harris, Ray-Whay Chiu Yen, Nita Ahuja, Malcolm V. Brock, Vered Stearns, David Feller-Kopman, Lonny B. Yarmus, Yi-Chun Lin, Alana L. Welm, Jean-Pierre Issa, Il Minn, William Matsui, Yoon-Young Jang, Saul J. Sharkis, Stephen B. Baylin & Cynthia A. Zahnow. (2012) Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells. Cancer Cell 21:3, pages 430-446.
Crossref
Crossref
Kaiji Hu, Jennifer H Law, Abbas Fotovati & Sandra E Dunn. (2012) Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells. Breast Cancer Research 14:1.
Crossref
Crossref
Joshua S. Silverman, Jeffrey R. Skaar & Michele Pagano. (2012) SCF ubiquitin ligases in the maintenance of genome stability. Trends in Biochemical Sciences 37:2, pages 66-73.
Crossref
Crossref
Navjotsingh Pabla, Kirti Bhatt & Zheng Dong. (2011) Checkpoint kinase 1 (Chk1)-short is a splice variant and endogenous inhibitor of Chk1 that regulates cell cycle and DNA damage checkpoints. Proceedings of the National Academy of Sciences 109:1, pages 197-202.
Crossref
Crossref
Anren Song, Jean Wu, Emily Whitaker & Nadarajah Vigneswaran. (2012) Gemcitabine Inhibits Murine Head and Neck Squamous Cell Carcinoma Growth via Proteasome-Dependent Degradation of Chk1 Leading to Cell Cycle Arrest and Apoptosis. Journal of Cancer Therapy 03:05, pages 562-574.
Crossref
Crossref
G Lossaint, E Besnard, D Fisher, J Piette & V Dulić. (2011) Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional. Oncogene 30:41, pages 4261-4274.
Crossref
Crossref
LiFeng Ning, HuiPing Wang, Dan San & JianLi Sang. (2011) C-terminal domain of Chk1 regulates its subcellular location and kinase activity for DNA repair. Chinese Science Bulletin 56:30.
Crossref
Crossref
Ariel Bensimon, Ruedi Aebersold & Yosef Shiloh. (2011) Beyond ATM: The protein kinase landscape of the DNA damage response. FEBS Letters 585:11, pages 1625-1639.
Crossref
Crossref
Wonil Koh, Soo-Jin Jeong, Hyo-Jung Lee, Ho-Geon Ryu, Eun-Ok Lee, Kyoo Seok Ahn, Hyunsu Bae & Sung-Hoon Kim. (2011) Melatonin promotes puromycin-induced apoptosis with activation of caspase-3 and 5′-adenosine monophosphate-activated kinase-alpha in human leukemia HL-60 cells. Journal of Pineal Research 50:4, pages 367-373.
Crossref
Crossref
Dorota Rybaczek & Magdalena Kowalewicz-Kulbat. (2011) Premature chromosome condensation induced by caffeine, 2-aminopurine, staurosporine and sodium metavanadate in S-phase arrested HeLa cells is associated with a decrease in Chk1 phosphorylation, formation of phospho-H2AX and minor cytoskeletal rearrangements. Histochemistry and Cell Biology 135:3, pages 263-280.
Crossref
Crossref
Cynthia X. Ma, James W. Janetka & Helen Piwnica-Worms. (2011) Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics. Trends in Molecular Medicine 17:2, pages 88-96.
Crossref
Crossref
Ernest K. Boamah, Angelika Brekman, Maria Tomasz, Natura Myeku, Maria Figueiredo-Pereira, Senyene Hunter, Joel Meyer, Rahul C. Bhosle & Jill Bargonetti. (2010) DNA Adducts of Decarbamoyl Mitomycin C Efficiently Kill Cells without Wild-Type p53 Resulting from Proteasome-Mediated Degradation of Checkpoint Protein 1. Chemical Research in Toxicology 23:7, pages 1151-1162.
Crossref
Crossref